Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ion Beam Applications S.A. (IBAB.BR)
EUR16.82
-0.02 (-0.12%)
BE BRU Healthcare Medical - Devices
Address
3, Chemin du Cyclotron 1348
Louvain-la-Neuve, BE
Louvain-la-Neuve, BE
CEO
Olivier Legrain
Website
iba-worldwide.com
IPO
2000-01-04
ISIN BE0003766806
Also trades on
Euronext Brussels · IBAB.BR (EUR)
Other OTC · IOBCF (USD)
Description
Ion Beam Applications S.A. (IBA) specializes in the creation, production, and maintenance of advanced medical equipment and software systems designed to combat cancer, operating across Belgium, the United States, and numerous other countries. Its operations are structured into two key divisions: Proton Therapy and Other Accelerators, and Dosimetry. The Proton Therapy and Other Accelerators segment is dedicated to the engineering, manufacturing, and upkeep of both clinical and industrial particle accelerators, including cutting-edge proton therapy apparatus. This division also furnishes comprehensive, ready-to-use systems for treating cancer with proton beams, a range of cyclotrons crucial for generating radioisotopes for PET and SPECT imaging, as well as industrial accelerators employed in sterilization and ionization processes. The Dosimetry segment offers instruments and expertise aimed at improving the precision and reducing errors in radiation therapy, medical imaging quality assurance, and calibration. IBA maintains a crucial research and development alliance with the Belgian nuclear research center, SCK CEN, to facilitate the development of Actinium-225 (225Ac), an innovative radioisotope with potential in cancer therapy, and collaborates with the University of Pennsylvania on pioneering research into ConformalFLASH technology. Established in 1986, the company's headquarters are located in Louvain-la-Neuve, Belgium.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR16.82
-0.02 (-0.12%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
38.2K
Beta
1.23
Float Shares
19.57M
Free Float %
66.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.63% | +1.68% | +17.49% | +2.21% | +39.61% | +21.67% | +29.92% | +2.88% | -5.42% | -59.00% | -70.34% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
16.82
DCF (Unlevered)
2.77
-83.5%
DCF (Levered)
6.76
-59.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
50% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.38
Grey zone
Piotroski F-Score
4 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+24.5% ★ Q4'25: +21.6% (vs Q4'23)
-
EPS growth Medical - Devices: +28.5%+38.7% ★ Q4'25: -16.1% (vs Q4'23)
-
FCF margin FCF growth · Medical - Devices: +30.9%-5.7% Q4'25: +2.1% (vs Q4'23)
-
EBIT margin Medical - Devices: +6.2%+4.4% Q4'25: +5.3% (vs Q4'23)
-
ROIC Medical - Devices: +3.3%+10.5% ★ Q4'25: +32.8% (vs Q4'23)
-
Share dilution Medical - Devices: 0.0%-2.5% ★ Q4'25: +1.3% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×2.85× Q4'25: 1.22× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 1999 actual |
Dec 2000 actual |
Dec 2001 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 1 EPS Ana. |
Dec 2027 3 Rev. Ana. 1 EPS Ana. |
Dec 2028 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
167.13M
est.
|
244.06M
est.
|
255.01M
est: 261.49M (-2.5%)
|
271.95M
est: 279.12M (-2.6%)
|
253.20M
est: 261.90M (-3.3%)
|
188.88M
est: 181.47M (+4.1%)
|
136.10M
est: 135.30M (+0.6%)
|
170.26M
est: 163.25M (+4.3%)
|
213.85M
est: 201.05M (+6.4%)
|
332.61M
est: 317.88M (+4.6%)
|
332.61M
est: 376.45M (-11.6%)
|
387.59M
est: 381.71M (+1.5%)
|
237.69M
est: 416.31M (-42.9%)
|
221.11M
est: 326.82M (-32.3%)
|
212.51M
est: 318.71M (-33.3%)
|
220.58M
est: 300.74M (-26.7%)
|
270.36M
est: 263.20M (+2.7%)
|
328.77M
est: 324.58M (+1.3%)
|
236.49M
est: 335.63M (-29.5%)
|
257.41M
est: 284.17M (-9.4%)
|
282.55M
est: 264.06M (+7.0%)
|
311.96M
est: 294.31M (+6.0%)
|
312.96M
est: 312.61M (+0.1%)
|
361.27M
est: 352.85M (+2.4%)
|
428.72M
est: 465.75M (-8.0%)
|
498.20M
est: 468.25M (+6.4%)
|
620.20M
est: 613.50M (+1.1%)
|
633.80M
605.43M – 649.59M
+3.3% YoY
|
641.35M
631.93M – 651.75M
+1.2% YoY
|
665.45M
645.85M – 679.09M
+3.8% YoY
|
| EBITDA |
56.58M
est.
|
31.66M
est.
|
68.92M
est: 45.09M (+52.8%)
|
57.74M
est: 41.12M (+40.4%)
|
47.36M
est: 25.02M (+89.2%)
|
56.26M
est: -43.53M (+229.2%)
|
17.68M
est: 15.39M (+14.9%)
|
37.06M
est: 27.92M (+32.7%)
|
15.92M
est: 44.05M (-63.9%)
|
41.68M
est: 23.10M (+80.4%)
|
25.72M
est: 31.25M (-17.7%)
|
26.00M
est: 14.91M (+74.4%)
|
49.37M
est: 29.33M (+68.3%)
|
-6.35M
est: 8.09M (-178.5%)
|
6.85M
est: -10.78M (+163.5%)
|
24.37M
est: 2.41M (+909.6%)
|
71.42M
est: 17.23M (+314.5%)
|
34.05M
est: 86.61M (-60.7%)
|
-15.65M
est: 32.02M (-148.9%)
|
9.58M
est: -15.40M (+162.2%)
|
28.10M
est: 3.66M (+668.3%)
|
51.62M
est: 21.49M (+140.2%)
|
23.12M
est: 20.95M (+10.3%)
|
13.13M
est: 22.04M (-40.4%)
|
19.13M
est: 25.57M (-25.2%)
|
26.70M
est: 25.64M (+4.2%)
|
41.00M
est: 33.69M (+21.7%)
|
34.80M
33.24M – 35.67M
+3.3% YoY
|
35.21M
34.70M – 35.79M
+1.2% YoY
|
36.54M
35.46M – 37.29M
+3.8% YoY
|
| EBIT |
16.02M
est.
|
15.63M
est.
|
-2.51M
est: 19.18M (-113.1%)
|
1.48M
est: -17.08M (+108.6%)
|
-86.31M
est: -7.79M (-1,008.3%)
|
35.68M
est: -70.54M (+150.6%)
|
6.85M
est: 4.85M (+41.2%)
|
26.31M
est: -1.81M (+1,553.5%)
|
11.22M
est: 24.88M (-54.9%)
|
14.06M
est: 11.07M (+27.0%)
|
4.45M
est: 20.25M (-78.0%)
|
17.98M
est: -3.25M (+652.8%)
|
621.0K
est: 6.33M (-90.2%)
|
-20.43M
est: -2.04M (-900.8%)
|
4.36M
est: -10.53M (+141.4%)
|
22.40M
est: 511.4K (+4,279.0%)
|
26.23M
est: 20.38M (+28.7%)
|
31.54M
est: 74.53M (-57.7%)
|
-22.51M
est: 30.03M (-175.0%)
|
1.42M
est: -18.33M (+107.7%)
|
13.25M
est: 2.88M (+359.7%)
|
39.66M
est: 17.44M (+127.5%)
|
13.23M
est: 17.00M (-22.2%)
|
2.42M
est: 17.88M (-86.5%)
|
7.61M
est: 13.12M (-42.0%)
|
15.00M
est: 13.15M (+14.1%)
|
27.30M
est: 17.28M (+58.0%)
|
17.85M
17.05M – 18.30M
+3.3% YoY
|
18.06M
17.80M – 18.36M
+1.2% YoY
|
18.74M
18.19M – 19.13M
+3.8% YoY
|
| Net Income |
7.42M
est.
|
4.97M
est.
|
-24.07M
est: 7.50M (-420.9%)
|
-21.74M
est: -25.62M (+15.1%)
|
-124.68M
est: -20.08M (-520.9%)
|
6.68M
est: -85.64M (+107.8%)
|
3.05M
est: 5.29M (-42.4%)
|
30.01M
est: 3.62M (+729.0%)
|
13.85M
est: 36.95M (-62.5%)
|
5.33M
est: 21.98M (-75.8%)
|
5.33M
est: 6.28M (-15.1%)
|
6.64M
est: -12.70M (+152.3%)
|
-84.13M
est: 6.76M (-1,344.1%)
|
-5.80M
est: -66.18M (+91.2%)
|
-4.10M
est: -5.50M (+25.5%)
|
24.29M
est: 6.24M (+289.4%)
|
61.19M
est: 22.31M (+174.3%)
|
24.44M
est: 73.45M (-66.7%)
|
-41.66M
est: 25.13M (-265.8%)
|
-4.40M
est: -34.54M (+87.3%)
|
7.61M
est: -3.79M (+300.7%)
|
31.92M
est: 9.06M (+252.3%)
|
3.88M
est: 8.83M (-56.1%)
|
6.06M
est: -19.49M (+131.1%)
|
-9.11M
est: 7.85M (-216.0%)
|
9.30M
est: 5.17M (+79.9%)
|
12.70M
est: 11.08M (+14.7%)
|
31.21M
29.76M – 32.66M
+181.8% YoY
|
30.80M
27.17M – 36.03M
-1.3% YoY
|
42.10M
39.48M – 42.15M
+36.7% YoY
|
| SGA |
23.05M
est.
|
52.57M
est.
|
61.51M
est: 58.82M (+4.6%)
|
59.72M
est: 70.56M (-15.4%)
|
52.32M
est: 61.18M (-14.5%)
|
33.83M
est: 37.83M (-10.6%)
|
18.85M
est: 19.83M (-5.0%)
|
17.73M
est: 37.52M (-52.7%)
|
40.89M
est: 41.26M (-0.9%)
|
74.58M
est: 64.67M (+15.3%)
|
74.58M
est: 88.34M (-15.6%)
|
103.73M
est: 96.53M (+7.5%)
|
59.28M
est: 66.64M (-11.0%)
|
46.49M
est: 40.74M (+14.1%)
|
47.22M
est: 66.81M (-29.3%)
|
50.40M
est: 52.16M (-3.4%)
|
57.92M
est: 46.73M (+24.0%)
|
69.62M
est: 71.94M (-3.2%)
|
57.37M
est: 73.91M (-22.4%)
|
60.78M
est: 52.62M (+15.5%)
|
61.92M
est: 52.17M (+18.7%)
|
62.53M
est: 71.01M (-11.9%)
|
59.17M
est: 69.23M (-14.5%)
|
73.88M
est: 72.82M (+1.4%)
|
80.10M
est: 87.56M (-8.5%)
|
90.70M
est: 87.77M (+3.3%)
|
110.10M
est: 115.33M (-4.5%)
|
119.15M
113.82M – 122.12M
+3.3% YoY
|
120.57M
118.80M – 122.53M
+1.2% YoY
|
125.10M
121.42M – 127.66M
+3.8% YoY
|
| EPS |
0.80
est.
|
1.03
est.
|
-0.82
est: -0.16 (-427.2%)
|
-0.74
est: -0.30 (-147.3%)
|
-5.08
est: -0.73 (-591.7%)
|
0.25
est: 0.27 (-5.7%)
|
0.12
est: 0.38 (-68.6%)
|
1.19
est: 0.21 (+473.8%)
|
0.54
est: 0.45 (+19.2%)
|
-0.48
est: 0.51 (-193.5%)
|
-0.48
est: -0.20 (-142.6%)
|
0.24
est: 0.27 (-9.5%)
|
-3.18
est: 0.09 (-3,642.8%)
|
-0.22
est: -0.40 (+44.7%)
|
-0.15
est: 0.16 (-191.9%)
|
0.75
est: 0.59 (+26.8%)
|
2.17
est: 0.79 (+173.4%)
|
0.85
est: 0.97 (-12.2%)
|
-1.43
est: -0.14 (-946.3%)
|
-0.15
est: -0.03 (-382.3%)
|
0.26
est: 0.13 (+100.7%)
|
1.08
est: 0.74 (+46.0%)
|
0.13
est: 0.08 (+65.3%)
|
0.21
est: 0.11 (+90.9%)
|
-0.31
est: 0.27 (-215.1%)
|
0.31
est: 0.18 (+77.1%)
|
0.43
est: 0.38 (+14.7%)
|
1.06
1.01 – 1.11
+181.8% YoY
|
1.07
0.92 – 1.22
+1.3% YoY
|
1.39
1.34 – 1.43
+29.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-28 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-27 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-14 | B | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-12 | B | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-05 | B | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-04 | B | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-30 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-6.59M
OE per share TTM
-0.29
Owner's Yield
-1.42%
Maintenance CapEx ratio
13.96%
Maint CapEx / Avg PPE
12.5%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 12 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Europe SmallCap Dividend UCITS ETF WTES.DE | 0.12% | 109.4K | 0.38% |
| 2 | WisdomTree Europe SmallCap Dividend UCITS ETF Acc DFEA.L | 0.12% | 109.4K | 0.38% |
| 3 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.06% | 250.3K | 0.48% |
| 4 | WisdomTree International SmallCap Dividend Fund DLS | 0.05% | 472.8K | 0.58% |
| 5 | iShares International Small-Cap Equity Factor ETF ISCF | 0.03% | 212.6K | 0.24% |
| 6 | Avantis International Small Cap Value ETF AVDV | 0.02% | 3.64M | 0.36% |
| 7 | Dimensional - International Small Cap ETF DFIS | 0.00% | 197.3K | 0.39% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 66.4K | 0.28% |
| 9 | Dimensional - International Vector Equity ETF DXIV | 0.00% | 556.15 | 0.53% |
| 10 | Avantis International Equity ETF AVDE | 0.00% | 40.4K | 0.23% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
12.9K
Shares Outstanding
29.33M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Olivier Legrain | Chief Executive Officer, MD & Executive Director | 980.8K | male |
| Yves Jongen | Founder, Chief Research Officer & Executive Director | 783.3K | male |
| Henri de Romree | Deputy Chief Executive Officer, Internal Director & Managing Director | 580.7K | male |
| Catherine Vandenborre | CFO, Head of IBA Corporate & Corporate Lead | 246.7K | female |
| Pierre Mottet | Chairman of the Board | 77.3K | male |
| Olivier Lechien | Corporate Communication Director | — | — |
| Thomas Canon | Sustainability Program Director | — | — |
| Bruno Scutnaire | President of IBA RadioPharma Solutions | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IBAB.BR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
